Literature DB >> 17171413

Contractile responses of rabbit bladder neck to adrenaline, acetylcholine and papaverine after doxazosin treatment.

Muzaffer Eroglu1, Aysun Sezgin, Atilla Semercioz, Ahmed Metin, Engin Kandirali, M Ali Onur.   

Abstract

It has been demonstrated that long-term administration of doxazosin, an alpha 1 adrenoceptor antagonist, causes an up-regulation in the expression of alpha 1 adrenoceptor subtype mRNAs in the rat genitourinary tract. The aim of this study is to determine whether this up-regulation does have any effect on contractile response of rabbit bladder neck to adrenaline, acethylcholine and papaverin after long-term doxazosin treatment. Fourteen rabbits, treated with doxazosin 3 mg/kg/day p.o for 6 months, and were fed with a diet of standard laboratory rabbit chow (100 g/kg/day). Ten rabbits received the same amount of regular chow but no drug. Contractile responses of rabbit bladder neck to adrenaline acethylcholine and papaverine were measured.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171413     DOI: 10.1007/s11255-006-9047-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  12 in total

1.  Excitatory alpha1-adrenergic receptors predominate over inhibitory beta-receptors in rabbit dorsal detrusor.

Authors:  Eric Chieh-Lung Chou; Seth A Capello; Robert M Levin; Penelope A Longhurst
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

2.  A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

Authors:  B Djavan; M Marberger
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

Review 3.  Alpha1-blocker therapy for lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the relevant differences in randomised controlled trials?

Authors: 
Journal:  Eur Urol       Date:  2000       Impact factor: 20.096

4.  Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat.

Authors:  M L Cohen; K Drey
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

5.  Evidence for predominant mediation of alpha1-adrenoceptor in the tonus of entire urethra of women.

Authors:  N Taki; T Taniguchi; K Okada; N Moriyama; I Muramatsu
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

6.  Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling.

Authors:  Makoto Yono; Harris E Foster; David Shin; Shrikant Mane; Jamshid Latifpour
Journal:  Life Sci       Date:  2005-02-05       Impact factor: 5.037

Review 7.  Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists.

Authors:  Shirin Milani; Bob Djavan
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

Review 8.  After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia.

Authors:  Sheila A Doggrell
Journal:  Expert Opin Pharmacother       Date:  2004-09       Impact factor: 3.889

9.  Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy.

Authors:  S Furuya; Y Kumamoto; E Yokoyama; T Tsukamoto; T Izumi; Y Abiko
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

10.  Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta.

Authors:  Makoto Yono; Harris E Foster; David Shin; Wataru Takahashi; Mehdi Pouresmail; Jamshid Latifpour
Journal:  Life Sci       Date:  2004-10-08       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.